NYSE: RDY
Dr Reddys Laboratories Ltd Stock Ownership - Who owns Dr Reddys Laboratories?

Insider buying vs selling

Have Dr Reddys Laboratories Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RDY insiders and whales buy or sell their stock.

RDY Shareholders

What type of owners hold Dr Reddys Laboratories Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robeco Institutional Asset Management Bv1.46%12,163,428$176.49MInstitution
Blackrock Inc1.25%10,436,247$151.43MInstitution
Royal Bank Of Canada1.19%9,962,048$144.55MInstitution
Renaissance Technologies LLC1.08%9,013,128$130.78MInstitution
Aikya Investment Management Ltd0.76%6,354,979$92.21MInstitution
Jpmorgan Chase Co0.71%5,910,786$85.77MInstitution
Dimensional Fund Advisors LP0.65%5,400,530$78.36MInstitution
Vanguard Group Inc0.60%4,975,047$72.19MInstitution
Morgan Stanley0.58%4,854,849$70.44MInstitution
State Street Corp0.50%4,192,235$60.83MInstitution

1 of 3

RDY vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RDY12.88%0.00%
VTRS82.05%17.95%Net SellingNet Buying
NBIX70.97%29.03%Net SellingNet Selling
ELAN91.27%8.73%Net SellingNet Selling
RGC0.14%0.00%

Dr Reddys Laboratories Stock Ownership FAQ

Who owns Dr Reddys Laboratories?

Dr Reddys Laboratories (NYSE: RDY) is owned by 12.88% institutional shareholders, 0.00% Dr Reddys Laboratories insiders, and 87.12% retail investors. Robeco Institutional Asset Management Bv is the largest individual Dr Reddys Laboratories shareholder, owning 12.16M shares representing 1.46% of the company. Robeco Institutional Asset Management Bv's Dr Reddys Laboratories shares are currently valued at $176.49M.

If you're new to stock investing, here's how to buy Dr Reddys Laboratories stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.